Typical and Atypical Enzyme Kinetics
- 3 September 2003
- book chapter
- Published by Taylor & Francis
Abstract
Critical in the elimination of drugs and other xenobiotics from the body, cytochrome P450 has strong bearing on scientific assessments of genetic polymorphism in metabolism, possible drug-drug interactions, and bioavailability of candidate drugs. This text systematizes findings on P450 and similar enzymes - as well as parallel issues shaping the pharmaceutical industry - to promote the next generation of safer, more effective drugs. Critical in the elimination of drugs and other xenobiotics from the body, cytochrome P450 has strong bearing on scientific assessments of genetic polymorphism in metabolism, possible drug-drug interactions, and bioavailability of candidate drugs. This text systematizes findings on P450 and similar enzymes - as well as parallel issues shaping the pharmaceutical industry - to promote the next generation of safer, more effective drugs. Critical in the elimination of drugs and other xenobiotics from the body, cytochrome P450 has strong bearing on scientific assessments of genetic polymorphism in metabolism, possible drug-drug interactions, and bioavailability of candidate drugs. This text systematizes findings on P450 and similar enzymes - as well as parallel issues shaping the pharmaceutical industry - to promote the next generation of safer, more effective drugs. Critical in the elimination of drugs and other xenobiotics from the body, cytochrome P450 has strong bearing on scientific assessments of genetic polymorphism in metabolism, possible drug-drug interactions, and bioavailability of candidate drugs. This text systematizes findings on P450 and similar enzymes - as well as parallel issues shaping the pharmaceutical industry - to promote the next generation of safer, more effective drugs. Critical in the elimination of drugs and other xenobiotics from the body, cytochrome P450 has strong bearing on scientific assessments of genetic polymorphism in metabolism, possible drug-drug interactions, and bioavailability of candidate drugs. This text systematizes findings on P450 and similar enzymes - as well as parallel issues shaping the pharmaceutical industry - to promote the next generation of safer, more effective drugs. Critical in the elimination of drugs and other xenobiotics from the body, cytochrome P450 has strong bearing on scientific assessments of genetic polymorphism in metabolism, possible drug-drug interactions, and bioavailability of candidate drugs. This text systematizes findings on P450 and similar enzymes - as well as parallel issues shaping the pharmaceutical industry - to promote the next generation of safer, more effective drugs.Keywords
This publication has 32 references indexed in Scilit:
- Microsomal Protein Concentration Modifies the Apparent Inhibitory Potency of CYP3A InhibitorsDrug Metabolism and Disposition, 2002
- Optimizing drug development: Strategies to assess drug metabolism/transporter interaction potential-toward a consensusClinical Pharmacology & Therapeutics, 2001
- Minimal in vivo activation of CYP2C9-mediated flurbiprofen metabolism by dapsoneEuropean Journal of Pharmaceutical Sciences, 2001
- Fluorometric screening for metabolism-based drug–drug interactionsJournal of Pharmacological and Toxicological Methods, 2000
- Nonspecific binding of drugs to human liver microsomesBritish Journal of Clinical Pharmacology, 2000
- Effects of Human Cytochrome b5on CYP3A4 Activity and Stabilityin VivoArchives of Biochemistry and Biophysics, 1999
- CYTOCHROME P-450 3A4: Regulation and Role in Drug MetabolismAnnual Review of Pharmacology and Toxicology, 1999
- Evaluation of Atypical Cytochrome P450 Kinetics with Two-Substrate Models: Evidence That Multiple Substrates Can Simultaneously Bind to Cytochrome P450 Active SitesBiochemistry, 1998
- Reconstitution Premixes for Assays Using Purified Recombinant Human Cytochrome P450, NADPH-Cytochrome P450 Reductase, and Cytochromeb5Archives of Biochemistry and Biophysics, 1997
- Cooperativity in Oxidations Catalyzed by Cytochrome P450 3A4Biochemistry, 1997